PURMX Therapeutics Raised Funds through a Third-party Allotment of New Shares from Yokohama Capital
- PURMX Therapeutics
- Nov 30, 2023
- 1 min read
Updated: May 22, 2024
We are pleased to announce that PURMX Therapeutics, Inc. (headquartered in Hiroshima City, Japan; Hidetoshi Tahara, President & CEO; hereinafter referred to as "the Company") has raised capital through a third-party allotment to Yokohama Next Investment Limited Liability Partnership.
Kommentare